Jeff Stoll's Biography

Jeff Stoll, Vice President, Life Sciences, Ernst & Young LLP

Prior to EY, Jeff was a Vice President at Scientia Advisors where he developed and lead the TA and Product Strategy practice, a global practice focused on product and TA strategy, corporate strategy, and deal diligence. Prior to joining Scientia Advisors, Jeff was the therapeutic leader for inflammatory diseases and CNS at IMS Health where he focused on commercial strategy, due diligence and therapeutic area assessment for several top 15 global pharmaceutical clients. Prior to joining IMS Health, Jeff was a Assistant Professor at the University of Florida (Shands Hospital) where he was a member of the medical review boards for heart, lung, liver and kidney transplant services.